Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding Brian's proposal

I2007s wrote "Three people run this company...three people and their collective wisdom (Joke) make all the decisions in spite of what shareholders want. "

For once I don't totally agree. Literally speaking, Laurie is right. But in practice PTSC relies almost entirely on TPL for its meagre income and allegedly must seek the approval of TPL for any announcements with relevance to MMP. Even in the PTSC FAQs there is the statement regarding the TPL Settlement that "Confidentiality was not our preference..." which reinforces the power that TPL wields over PTSC communications.

Does PTSC control the marketing, sales and pricing of its primary asset? No.
Does PTSC have control over the costs charged by TPL for MMP activity? Apparently not.
Does PTSC have unrestricted freedom to communicate with its shareholders? No.

To my mind, the Leckrones and TPL effectively determine the income stream and outward communication content of PTSC as well as being the beneficiary of a large part of PTSC's expenditures and thus have the greater impact to "running" PTSC.

The associated PTSC subsidiary, PDS, seems to be just another vehicle to (a) drain precious PTSC funds and (b) pay Carlton Johnson an additional stipend out of PTSC funds.

Share
New Message
Please login to post a reply